Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs

Pedro Luis Gonzalez MD, MT, Urania Rappo MD, Karthik Akinapelli MS, Jennifer S McGregor RPh, Sailaja Puttagunta MD, Michael W Dunne MD

Article Type

Original Research

Published

This subgroup analysis sought to more fully characterize the demographics, baseline characteristics, safety, and efficacy of
dalbavancin in the persons who inject drugs (PWID) and non-PWID population and as a single-dose therapy versus 2-dose therapy from a previously published global trial.

Read more

How to manage Pseudomonas aeruginosa infections

Matteo Bassetti MD, PhD, Antonio Vena MD, Antony Croxatto PhD, Elda Righi MD, PhD, Benoit Guery MD, PhD

Article Type

Review

Published

This review looks at the mechanisms associated with resistance to Pseudomonas aeruginosa, as well as antibiotic combinations and limitations of current therapies, and the potential for alternative drugs and new therapeutic options are also discussed.

Read more

Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands

George Kassianos, Patricia Blank, Oana Falup-Pecurariu, Ernest Kuchar, Jan Kyncl, Raul Ortiz De Lejarazu, Aneta Nitsch-Osuch, Gerrit A Van Essen

Article Type

Original Research

Published

In this article the authors aim to harmonise the diagnosis of seasonal influenza and the approach of European general practitioners to vaccination in order to better identify influenza outbreaks and achieve a target vaccination rate of 75% throughout Europe.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.